Vivaldi BioSciences Lands $15,683,200 New Round

  • Feed Type
  • Date
    12/31/2008
  • Company Name
    Vivaldi BioSciences
  • Mailing Address
    750 Battery Street San Francisco, CA 94111
  • Company Description
    The company is developing influenza-targeted vaccines and therapeutics.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,683,200
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Alexandria Real Estate Equities, Inc.
  • Venture Investor
    Bay City Capital
  • Venture Investor
    NGN Capital
  • Venture Investor
    New York City Investment Fund

Trending on Xconomy